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Pomace olive oil (POM), an olive oil subproduct traditionally used in Spain, is a good source of minor components from the unsaponifiable
fraction such as triterpenoids, mainly in the form of oleanolic acid, which induces vascular protection and vasodilatation. Our aim was to evaluate
the effects of long-term intake of diets enriched in POM with high concentration in oleanolic acid on endothelial dysfunction associated to hyper-
tension in small mesenteric arteries (SMA) from spontaneously hypertensive rats (SHR). During 12 weeks, rats (six rats per group) were fed
either a control 2 % maize oil diet (BD), or high-fat diets containing 15 % refined olive oil (OL), pomace olive oil (POM), or pomace olive
oil supplemented in oleanolic acid (POMO; up to 800 parts per million). Endothelial and vascular functions were assessed by relaxing or contract-
ing responses to acetylcholine (ACh) or phenylephrine, respectively. The involvement of endothelium-derived relaxing factors in these responses
was evaluated. In contrast to BD, SHR fed high-fat diets showed a biphasic response to ACh related to changes in eicosanoid metabolism. POM
enhanced the endothelial function in SMA from SHR by increasing the endothelium-derived hyperpolarising factor (EDHF)-type component,
whereas administration of POMO resulted in a similar contribution of NO/EDHF in the endothelial response to ACh. The present study shows
that despite the lack of changes in blood pressure, consumption of POM improves endothelial function in SMA from SHR by improving the
agonist-mediated EDHF/NO response. Thus, triterpenoids confer a protective role to POM against endothelial dysfunction in hypertension.
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Arterial hypertension is the most common cause of cardio-
vascular and cerebrovascular complications in human subjects.
Although effective pharmacological strategies for the treat-
ment of hypertension exist, there is a great deal of interest
in using dietary approaches to attenuate the cardiovascular
disorders associated to hypertension. Over the years, a
number of epidemiological and clinical studies developed in
different countries constitute a firm and reliable basis support-
ing the beneficial effect of the Mediterranean diet pattern,
containing olive oil as the main source of fat, against
CVD(1). An increasing number of evidences associate the
healthful effects of olive oil consumption on cardiovascular
risk factors with the presence of bioactive components in
this oil(2). Despite the attention paid to its high content in
MUFA such as oleic acid, minor components of olive oil
found in the non-glyceridic fraction may also explain the
cardioprotective effects of olive oil intake(3 – 5).
Among minor components from olive oil, interest on
its triterpenic fraction has been gaining importance in
recent years. The triterpenic fraction in olive oil and olive
skin is mainly constituted by pentacyclic terpenic acids (olea-
nolic and maslinic acid) and diols (erythrodiol and uvaol)(6).
The procedure applied for extraction of olive oil is important
for the content in triterpenoids and other minor constituents.
Pomace olive oil (POM; called in Spain as ‘orujo’ olive oil)
is obtained from the residue that remains after virgin olive
oil mechanical extraction. As a consequence of the extraction
processes needed to obtain both refined and POM, the hydro-
soluble fraction including phenolic compounds is lost. In spite
of the lack of phenolic compounds, POM, extracted using a
new procedure (patent number 200400755) contains higher
concentrations of triterpenic compounds than virgin olive
oil, the latter components exceeding values of 120 mg/kg.
Among olive and POM triterpenoids, oleanolic acid has
been the most widely studied and distributed in the vegetable
kingdom. In fact, a wide range of biological activities has been
attributed to this triterpenoid(3). Despite the lack of studies on
CVD, recent and novel data have suggested the vasoactive
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effects provided by POM and its triterpenoids in terms of
vasodilatation and endothelial function improvement(7 – 10).
The vascular endothelium is a major regulator of local vas-
cular homeostasis by the synthesis and release of vasoactive
factors promoting vasodilatation such as NO, prostacyclin
and endothelial derived hyperpolarising factor (EDHF), or
vasoconstriction, such as thromboxane A2, isoprostanes and
superoxide anion. Upsetting the balance between the pro-
duction of these substances leads to endothelial dysfunction,
frequently associated to hypertension(11). Our in vitro data
revealed that olive oil triterpenoids induce vasodilatation in
isolated conductance and resistance arteries from normoten-
sive and hypertensive rats(7 – 10). The vasodilatation response
was endothelium-dependent and mediated by mechanisms
involving NO release via phosphorylation of endothelial NO
(eNOS) at Ser1177 residues through Akt kinase activation(10).
Recently, we have shown that long-term intake of a POM-
rich diet in spontaneously hypertensive rats (SHR) resulted
in an improved endothelial function in large conductance
arteries without affecting blood pressure in vivo (7). It was
further determined that the POM-rich diet increased aortic
eNOS expression and plasmatic levels of NO metabolites
and the impaired endothelial function was reversed in animals
fed a POM-enriched diet for 3 months(7).
It has long been recognised that hypertension is strongly
linked to both functional and structural changes in micro-
circulation, which includes resistance arteries. Due to the
fact that changes in small resistance arteries are the hallmark
of hypertension, the present study was designed to evaluate
the effects of long-term intake of POM rich in triterpenoids
on hypertension-related endothelial dysfunction in small
mesenteric arteries (SMA) of SHR. We further examined the
contribution of endothelial-derived factors to these responses.
Experimental methods
Animals and diets
Three-week-old male Wistar–Kyoto (WKY) rats and SHR
were obtained from Charles River Laboratories (Barcelona,
Spain) and acclimatised for 1 week. The animals were ran-
domly distributed into four groups of six rats each, according
to diet and strain. During 12 weeks, animals were fed either a
control low-fat diet (baseline diet, BD) containing 2 % (w/w)
of maize oil, or high-fat diets containing 15 % (w/w) refined
olive oil (OL), POM, and POM supplemented in oleanolic
acid (800 ppm; POMO). The original POM and OL contained
approximately 200 and 25 parts per million of oleanolic acid,
respectively. According to the American Institute for Nutri-
tion, the BD contained sucrose 50 %, casein 23 %, maize
starch 15 %, a-cellulose 5 %, DL-methionine 0·3 % and choline
chloride 0·2 %, purchased from Musal & Chemical (Granada,
Spain), AIN-93-MX mineral mix 3·5 % and AIN-93-VX
vitamin mix 1 %, provided from ICN Nutritional Biochemicals
(Cleveland, OH, USA). Olive and POM were provided from
the olive oil-producing company Oleicola Oleotejar (Cordoba,
Spain), and maize oil from Koipe S.A. (Jaen, Spain)(7). Olea-
nolic acid was obtained by extraction from olive leaves, as
previously described(7). To minimise oxidation, all diets
were prepared weekly and stored at 48C as previously
described(12). The fatty and non-fatty acid composition of
the oils was analysed by GC in the company Oleicola Oleote-
jar (see composition of diets in Rodriguez-Rodriguez et al. (7)).
Food intake and corporal weight of the animals were
weekly determined. Systolic blood pressure and heart rate
were measured every week in conscious, prewarmed,
restrained rats by tail-cuff plethysmography with a pressure
meter (Niprem 645, Cibertec, Spain). The average of three
separate measurements was taken as the final reading. At the
end of the administration period, animals were anaesthetised
with pentobarbitone (60 mg/kg) and tissue was collected.
All protocols were approved by the Institutional Committee
on Investigation in Animals (Universidad de Sevilla,
Seville, Spain).
Arterial preparation
Segments of SMA (1·6–2 mm length) from WKY and SHR
rats were mounted in wire-myographs filled with physiological
salt solution (PSS; composition in mmol/l: NaCl 119, KCl 4·7,
NaHCO3 14·9, MgSO4 1·47, CaCl2 2·5, KH2PO4 0·4 and glu-
cose 5·5). Mechanical activity was measured isometrically by
a force transducer Multi Myograph System-610M (JP-Trading
I/S, Aarhus, Denmark) coupled to a Powerlab data acquisition
system (AD-Instruments, Bella Vista, New South Wales,
Australia) as previously described(13). After stabilisation,
challenges with 10mmol/l noradrenaline were performed in
SMA to test their maximal contractile response and to elicit
a reproducible contraction. The presence of functional
endothelium was determined by the ability of 1mmol/l acetyl-
choline (ACh) to induce more than 50 % of precontracted
vessels. In some arteries, endothelium was removed immedi-
ately after dissection by intraluminal perfusion with 0·5 %
3-[(3-cholamidopropyl) dimethylammonio]-1 propane sulpho-
nate (Sigma, St Louis, MO, USA) in PSS. The lack of relaxation
in response of ACh indicated a successful endothelial removal.
Measurement of vascular reactivity
The contractile responses evoked by cumulative addition of
phenylephrine (Phe; 0·01–100mmol/l) were studied in SMA
preparations with or without functional endothelium. Concen-
tration–response curves were referred to as contractions
previously elicited by noradrenaline. To test the influence of
endothelial NO on contractile responses to Phe, the same
experimental protocol was performed in the presence of the
NO synthase (NOS) inhibitor N v-nitro-L-arginine (L-NAME;
300mmol/l). Evaluation of endothelium-dependent relaxation
was also evaluated in SMA precontracted at 80 % of their
maximal contraction with Phe. When the contraction reached
a plateau, cumulative addition of ACh (0·01–100mmol/l) was
performed. Concentration–response curves for ACh were con-
structed in the absence or presence of the following inhibitors
at a maximally active concentration(14): the NOS inhibitor
L-NAME (300mmol/l), the non-selective cyclo-oxygenase
inhibitor indomethacin (10mmol/l), a combination of indo-
methacin (10mmol/l) þ L-NAME (300mmol/l; Sigma), PSS
containing depolarising concentrations of KCl (25 mmol/l) in
the presence of indomethacin and a combination of
indomethacin þ L-NAME þ PSS KCl 25 mmol/l to block the
EDHF-type relaxation. All the inhibitors were incubated for
15 min before the precontraction with Phe.
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Statistical analysis
Relaxations were expressed as a percentage from the initial
precontraction level and as means with their standard errors
for n experiments; n represents the number of rats. Area
under curves (AUC) were calculated from concentration–
response curves for the agonist. The maximum vasoconstrictor
response expressed as negative log molar (pD2 ¼ 2 log EC50)
was calculated by nonlinear regression analysis of each
individual concentration–response curve using GraphPad
Prism Software version 3.0 (San Diego, CA, USA). Data
were analysed using two-way ANOVA to compare concen-
tration–response curves to agonists. Differences between
means were assessed with Student’s t test for unpaired data.
Differences were considered significant when P,0·05.
A StatView Software package version 5.0 (SAS Institute
Inc., NY, USA) was used for statistical analysis.
Results
Weights, food consumption and blood pressure
At the end of the 12-week diet administration, body weight
and food intake values (weekly determined) were compared
between the experimental groups, and no differences were
appreciated. SHR developed hypertension at the age of
7 weeks, reaching values of systolic blood pressure signifi-
cantly higher (196·95 (SEM 3·57) mmHg) than in WKY
(157·63 (SEM 3·45) mmHg) after 12 weeks of treatment.
None of the experimental diets attenuated this systolic blood
pressure increase.
Contractile responses induced by phenylephrine
Concentration-dependent contractions evoked by Phe (0·01–
100mmol/l) in both WKY and SHR showed similar profile,
with similar pD2 values in endothelium-intact and -denuded
arteries from both strains (Table 1). Inhibition of NOS with
L-NAME enhanced Phe-induced contractions in SMA from
BD groups from both strains nearly 0·3-fold more than those
in control conditions (Fig. 1, Table 1). This fact unmasks
the participation of vasoconstrictor agents in Phe-responses
after NOS blockade in BD groups, in contrast to that observed
in SMA from high-fat diet treated groups. A significant attenu-
ation to Phe contractions was evidenced in the OL-fed SHR
group compared to strain-matched BD group, even in the
presence of L-NAME, whereas contractile responses to the
agonist remained unaltered in POM- or POMO-treated
groups (Fig. 1(B)).
Endothelium-dependent relaxations induced by acetylcholine
The muscarinic agonist ACh (0·01–100mmol/l) induced
relaxation in a concentration-dependent manner in SMA
with functional endothelium precontracted with Phe (Fig. 2).
Interestingly, the response curve to ACh in intact SMA from
SHR was biphasic, showing a first phase of relaxation
at ACh concentrations of 0·01–0·1mmol/l, contraction at
concentrations higher than 0·3mmol/l, and a second phase of
a lower extent of relaxation from 10mmol/l ACh (Fig. 2(B)).
Relaxation curve of ACh (0·01–100mmol/l) was notably
enhanced in SMA from POM-treated WKY rats compared
with strain-matched BD group (P,0·01; Fig. 2(A)). Further-
more, POM diet clearly modified the biphasic profile of con-
centration–response curves for ACh in SMA from SHR
(P,0·05; Fig. 2(B)). In this regard, the maximal relaxant
response to ACh 0·1mmol/l (first phase of the curve) was
increased from 23·42 (SEM 11·06) % in BD group to 52·59
(SEM 7·50) % in SHR fed a POM diet (P,0·05). It is
worthy to mention that the second phase of the concen-
tration–response curve for ACh, from 3 to 100mmol/l was
altered in SMA from POM- and POMO-treated SHR, showing
an evident relaxation, while this response was not detected in
arteries from BD or OL groups (Fig. 2(B)).
The involvement of the main endothelial factors mediating
the effect of ACh in resistance arteries, NO, cyclo-oxygense
(COX)-derived metabolites and EDHF was considered.
Table 1. pD2 and Emax values of concentration–response curves for phenylephrine (0·01–100mmol/l) in isolated small mesenteric
arteries with (E þ ) or without endothelium (E 2 ), or in the presence of the NO synthase inhibitor N v-nitro-L-arginine (L-NAME,
300mmol/l) in arteries with endothelium
(Mean values with their standard errors)
pD2 Emax (% maximal contraction)
E þ L-NAME E 2 E þ L-NAME E 2
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
WKY (n 6)
BD 5·55 0·05 5·77 0·04* 5·66 0·05 120·5 7·6 163·6 8·2 109·6 1·8
OL 5·68 0·13 5·77 0·09 5·74 0·05 104·9 5·2 112·2† 3·1 111·3 6·1
POM 5·74 0·08 5·77 0·06 5·77 0·09 112·2 3·2 116·9† 9·9 110·9 4·5
POMO 5·72 0·08 5·80 0·10 5·69 0·05 99·0† 6·2 92·7† 12·0 100·7 2·4
SHR (n 6)
BD 5·73 0·13 6·22 0·30 6·02 0·14 117·6 6·6 121·5 4·9 118·5 2·0
OL 5·26† 0·16 5·10† 0·21 5·52 0·15 95·5 10·5 116·4† 9·9 116·6 7·2
POM 5·49 0·14 5·69 0·13 5·67 0·15 123·3 10·4 138·8 11·9 114·7 3·7
POMO 5·47 0·10 5·65 0·16 5·55 0·04 122·6 12·7 143·3 19·5 122·0 9·7
WKY, Wistar–Kyoto; BD, basal diet; OL, refined olive oil diet; POM, pomace olive oil diet; POMO, POM supplemented in oleanolic acid diet; SHR,
spontaneously hypertensive rats.
*P,0·05 v. E(þ).
†P,0·05 v. BD.
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For this purpose, these factors were inhibited by incubation of
the preparation with L-NAME, indomethacin and PSS contain-
ing 25 mM-KCl (Figs. 3 and 4), respectively.
Involvement of cyclo-oxygense-derived metabolites
The presence of the COX inhibitor indomethacin significantly
improved the relaxant response to ACh in SMA from WKY
groups (Fig. 3). In these conditions, arteries from POMO
WKY exhibited a moderate contraction phase at higher con-
centrations of ACh after the maximal relaxation peak. In
SHR, COX inhibition also improved the relaxation to ACh
and partially attenuated the contractile component evoked by
the muscarinic agonist, indicating the potential participation
of vasoconstrictor products derived from COX in that response
(Fig. 4). Nevertheless, a residual contraction was still evident
in SMA from SHR fed OL- or POM-rich diets at high concen-
trations of ACh in the presence of indomethacin (Fig. 4). This
behaviour was much more evident in OL group. At this point,
the level of contraction exhibited by ACh in OL SHR group
was reached by an agonist concentration tenfold higher than
in POM group in the presence of indomethacin. These findings
suggest that different mediators rather than COX-derived
metabolites might be responsible for this response. In addition,
the improved relaxation observed in the presence of indo-
methacin was importantly stronger in SHR fed an OL diet,
suggesting the important role of contracting factors derived
from COX in this group.
Involvement of nitric oxide
In SMA from all groups of both WKY and SHR, the ACh-
evoked relaxation was significantly attenuated by exposure
to the NO synthesis inhibitor L-NAME (Figs. 3 and 4). This
fact supports the notion that NO is one of the main mediators
involved in the relaxation induced by ACh in SMA. Simul-
taneous blockade of COX and NOS by the combination of
indomethacin þ L-NAME attenuated the vasorelaxation for
all the groups of WKY and SHR, but this attenuation was
only partial and significantly lower than that exhibited in the
presence of L-NAME alone (Figs. 3 and 4). The fact that
ACh was able to induce relaxation in SMA in the presence
of indomethacin þ L-NAME even at greater extent than
after incubation of L-NAME alone is explained by the release
of an EDHF from the endothelium, which plays a major role
in the resistance vasculature.
Fig. 1. Area under the concentration–response curves (AUC) for phenylephrine (0·01–0100mmol/l) in isolated small mesenteric arteries (SMA) from either
Wistar–Kyoto (A) or spontaneously hypertensive rats (B) fed a control basal diet (BD), refined olive oil (OL), pomace olive oil (POM) or POM supplemented in
oleanolic acid (POMO) for 12 weeks. Curves were obtained in SMA with (E þ, B) or without endothelium (E 2, A) or intact preparations in the presence of the
NO synthase inhibitor N v-nitro-L-arginine (L-NAME; 300mmol/l; ). Values are means with their standard errors, n 6. Mean value was significantly different from
the diet-matched control E þ (*P,0·05, ***P,0·001). Mean value was significantly different from the BD group in the presence of L-NAME (†P,0·05,
††P,0·01).
Fig. 2. Concentration–response curves for acetylcholine (ACh; 0·01–100mmol/l) in endothelium-intact isolated small mesenteric arteries precontracted with
phenylephrine from either Wistar–Kyoto (A) or spontaneously hypertensive rats (B) fed a control basal diet (BD, P), refined olive oil (OL, K), pomace olive oil
(POM, W) or POM supplemented in oleanolic acid (POMO, X) for 12 weeks. Values are means with their standard errors, n 6. Mean value was significantly differ-
ent from the BD group (*P,0·05, **P,0·01).
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Involvement of endothelium-derived hyperpolarising factor
To test the involvement of the hyperpolarisation in the persist-
ing relaxation, concentration–response curves for ACh were
performed in 25 mmol/l Kþ media. Under these conditions,
relaxation to ACh was markedly inhibited in SMA from
both WKY and SHR (Figs. 5 and 6). In arteries from BD-
and OL-treated WKY rats, the combination of L-NAME þ
indomethacin in 25 mmol/l Kþ media attenuated the relaxant
response to the same extent as observed in this Kþ media
without inhibitors (Fig. 5(A), (B)). On the contrary, in SMA
from WKY fed POM- or POMO-rich diets inhibition of the
ACh vasorelaxation in 25 mmol/l Kþ media was significantly
strengthened by the simultaneous presence of L-NAME and
indomethacin in that media (Fig. 5(C), (D)). Regarding to
SHR, in SMA from OL and POM groups vasorelaxation to
ACh was similarly abolished by 25 mM-KCl either in the pre-
sence or absence of L-NAME þ indomethacin (Fig. 6(B),
(C)). In contrast, in BD and POMO-treated rats, the inhibition
of ACh-induced relaxation by 25 mM-KCl was strongly aug-
mented by the presence of both inhibitors (Fig. 6(A), (D)).
In addition, the differential participation of NO/COX-
derived metabolites and EDHF to the experimental groups
was further characterised determining the values derived
from the equations: AUCKClþindo þ L-NAME 2 AUCKCl and
AUCKClþindo þ L-NAME 2 AUCindoþL-NAME for NO/COX and
EDHF contribution, respectively. As illustrated in Fig. 7, the
contribution of EDHF in the endothelium-dependent vasore-
laxation to ACh was significantly higher than NO/COX in
SMA from normotensive rats in all the groups. No differences
were appreciated in the participation of the EDHF-type relax-
ation between the WKY groups. However, the participation of
NO/COX in the relaxant response was notably increased from
14·51 % in SMA from WKY rats fed a BD-rich diet to 54·98 %
in the POM group. According to SHR, the EDHF-type vasor-
elaxation showed similar values of contribution than those
exhibited in WKY, although this participation resulted signifi-
cantly attenuated in arteries from SHR fed an OL diet. Inter-
estingly, in resistance arteries from POM-treated SHR group,
the contribution of EDHF was markedly higher than the
NO/COX involvement (8·18 % of NO/COX contribution in
relation to EDHF), whereas similar level of contribution for
EDHF and NO/EDHF was detected in the POMO group.
Discussion
Numerous epidemiological studies have evidenced an inverse
relationship between olive oil consumption and the incidence
of cardiovascular risk factors including hypertension. The pre-
sent study shows functional and vasoactive changes induced
by long-term intake of olive oil and POM-enriched diets in
small resistance arteries (often referred to as the ‘hallmark’
of hypertension(15)) from SHR.
Fig. 3. Concentration–response curves for acetylcholine (ACh; 0·01–100mmol/l) in endothelium-intact isolated small mesenteric arteries (SMA) precontracted
with phenylephrine from Wistar–Kyoto rats fed a control basal diet (BD) (A), refined olive oil (OL) (B), pomace olive oil (POM) (C) or POM supplemented in
oleanolic acid (POMO) (D) for 12 weeks. Curves were obtained in SMA in the absence (W, taken as control) or presence of the NO synthase inhibitor N v-nitro-
L-arginine (L-NAME; 300mmol/l; X), the cyclo-oxygenase inhibitor indomethacin (10mmol/l; A) or indomethacin þ L-NAME (B). Values are means with their
standard errors, n 6. Mean value was significantly different from the control in the absence of inhibitors (*P,0·05, ***P,0·001). ††† Mean value was significantly
different from that in the presence of indomethacin þ L-NAME (P,0·001).
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Among all the environmental factors that affect arterial
hypertension, dietary habits play a prominent role in blood
pressure regulation and the associated endothelial dysfunc-
tion. Despite the ability of olive oil to modulate blood pressure
is less known than its effects on lipid metabolism, epidemio-
logical studies and feeding trials indicate that olive oil could
favourably affect the hypertensive state(16 – 18). Even though
the mechanisms and contribution of the different components
from olive oil affecting hypertension are not fully understood,
several authors suggest that this action is mediated by improv-
ing endothelial function(4,12,19). Human subjects’ and
experimental data propose that the beneficial effects of olive
oil consumption in hypertension and endothelial activation
are attributable to the content in oleic acid(17,20). Nevertheless,
olive oil is more than a monounsaturated fat, and minor
constituents from olive oil such as phenolic compounds
are also considered responsible for the cardiovascular protec-
tion(5,21). In the present study, we have used OL that are
lacking in phenolic compounds due to the refining process.
These OL contain similar proportion in oleic acid, but differ-
ent concentrations in minor components other than phenolic
compounds (e.g. triterpenoids).
The potential vasoactive effects of triterpenoids found in the
unsaponifiable fraction of olive oil are currently the subject of
interest. Although their presence in olive oil is very low, they
are found in important concentrations, up to 120 mg/kg, in
POM, obtained from the residue that remains after virgin
olive oil mechanical extraction(6). The vasodilator activity
of triterpenoids from olive and POM, mainly in the form of
oleanolic acid, has been evidenced in isolated aorta from
normo- and hypertensive rats(8,9). Oleanolic acid is also
able to substantially induce in vitro NO-mediated vasodilata-
tion in resistance arteries from the rat mesenteric vascular
bed, which are strongly involved in hypertension(10). Regard-
ing to in vivo evidences, SHR fed POM-enriched diets
demonstrated an increased vasodilatation to ACh in isolated
conductance arteries (aorta) compared to olive oil- or low
fat-treated animals(7). Those data support the notion than
other components, different from oleic acid such as triter-
penoids, found in the unsaponifiable fraction of the oils,
might be responsible for the effects of POM intake on endo-
thelial function. Supporting this background, the present
investigation showed how long-term intake of POM-enriched
diets containing substantial amounts of oleanolic acid, modi-
fied the vascular reactivity and endothelial responses in
SMA, importantly affected by the hypertensive state.
Resistance arteries from SHR are characterised by
endothelial dysfunction mainly associated to an impaired
ACh-induced relaxation(11,22). This is thought to be brought
about by an increased release of endothelium-derived
contracting factors, which are suggested to be a product of
arachidonic acid cascade synthesised via COX pathway,
since agents such as indomethacin can restore relaxation(22).
Therefore, the dysfunctional endothelium in SMA from SHR
is often characterised by a substantial co-release of vasocon-
strictor products derived from the COX pathway(13). In our
Fig. 4. Concentration–response curves for acetylcholine (ACh; 0·01–100mmol/l) in endothelium-intact isolated small mesenteric arteries (SMA) precontracted
with phenylephrine from spontaneously hypertensive rats fed a control basal diet (BD) (A), refined olive oil (OL) (B), pomace olive oil (POM) (C) or POM sup-
plemented in oleanolic acid (POMO) (D) for 12 weeks. Curves were obtained in SMA in the absence (W, taken as control) or presence of the NO synthase inhibitor
N v-nitro-L-arginine (L-NAME; 300mmol/l; X), the cyclo-oxygenase inhibitor indomethacin (10mmol/l; A) or indomethacin þ L-NAME (B). Values are means with
their standard errors, n 6. Mean value was significantly different from the control in the absence of inhibitors (*P,0·05, ***P,0·001). Mean value was significantly
different from that in the presence of indomethacin þ L-NAME (†P,0·05, ††P,0·01, †††P,0·001).
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investigation, BD control groups showed an improved Phe-
induced vasoconstriction after inhibition of NO production
by L-NAME, unmasking the participation of vasoconstrictor
metabolites from COX. This finding is in line with previous
evidence reporting that the reduced release of NO can
potentiate the release or the actions of endothelium-derived
contracting factors, which would increase sensitivity to Phe
and impair the relaxation(23). Our data also reported that all
the WKY groups evidenced a significant improvement in the
relaxant response to ACh in the presence of indomethacin,
revealing similar contribution of contracting factors derived
from COX to the vasoactive response.
Interestingly, we found a biphasic response induced by ACh
in SHR treated with high-fat diets (OL, POM, POMO) in
contrast to that observed in low-fat diet control (BD). This
fact may be explained by the relationship between the type
of oil consumed and the effect in the endothelial function. It
has been demonstrated that dietary oils influence the lipid
composition of postprandial TAG-rich protein particles
(TRL) including chylomicrons, VLDL, and their remnants(24).
These TRL can cross the endothelial barrier and enter into
the vascular wall, where they can differently modify the
endothelial function and atherogenesis depending on the com-
position of the oil consumed in the diet(24,25). TRL derived
from virgin olive oil intake with high content in unsaponifiable
fraction are known to reduce the release of proinflammatory
and prothrombotic substances that play important roles in
the dysfunction of the vascular reactivity(4). Specifically,
these TRL generated after virgin olive oil intake with high
concentration in minor constituents decreased the production
of COX-derived vasoconstrictor eicosanoids in vascular
endothelial cells compared to dietary oils of different compo-
sition(4). In line with these data, we may hypothesise that the
different composition in MUFA and minor constituents
between the oils tested in our investigation could be an
important factor determining differences in the endothelial-
dependent response to ACh. This might explain the biphasic
response to the muscarinic agonist in SHR fed high-fat
diets, but not in the control BD group. Furthermore, the fact
that, in SHR, the contractile phase of the dose–response
curves to ACh detected in high-fat dietary groups was clearly
attenuated by indomethacin, support the idea that eicosanoids
might be involved in the vasoactive effects of these olive
and POM diets on the endothelial function. According to the
earlier description, differential composition of the TRL
derived from the experimental diets could differently alter
vascular reactivity of SMA. In contrast, COX-derived meta-
bolites did not play a major role in the endothelial-dependent
response to ACh in conductance arteries (aorta) from SHR-fed
POM-enriched diets(7), indicating that the vascular effect of
these diets differs depending on the vascular arterial bed and
vessel diameter considered. In the present study, we also
observed a residual contraction resistant to indomethacin in
SMA from SHR fed an OL- or POM-enriched diet, which
Fig. 5. Concentration–response curves for acetylcholine (ACh; 0·01–100mmol/l) in endothelium-intact isolated small mesenteric arteries (SMA) precontracted
with phenylephrine from Wistar–Kyoto rats fed a control basal diet (BD) (A), refined olive oil (OL) (B), pomace olive oil (POM) (C) or POM supplemented in olea-
nolic acid (POMO) (D) for 12 weeks. Curves were obtained in SMA in the absence (W, taken as control) or presence of KCl 25 mmol/l (K), or KCl 25 mmol/l þ
indomethacin (10mmol/l) þ L-NAME (300mmol/l; O). Values are means with their standard errors, n 6. *** Mean value was significantly different from the control in
the absence of inhibitors (P,0·001). Mean value was significantly different from that in the presence of KCl 25 mmol/l þ indomethacin þ L-NAME (†P,0·05,
†††P,0·001).
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may be attributed to factors different from COX-derived
metabolites. Nevertheless, further studies are required to
better characterise the role of endothelial COX products in
rats after administration of olive and POM diets.
In addition to COX-derived mediators, endothelial cells
release the vasodilators NO and EDHF. The relative contri-
bution of both NO and EDHF varies among species, vascular
bed and vessel size(26). Particularly, in arterioles and small
arteries such as SMA, EDHF appears to be of major import-
ance, whereas in larger arteries such as aorta the role of NO
is more pronounced(26). Moreover, the EDHF-mediated hyper-
polarisation and relaxation mainly detected in small arteries
plays a pivotal role in the endothelial dysfunction in SHR
model, since chronic treatment of these animals with antihy-
pertensive agents markedly improved the EDHF system pre-
viously altered by hypertension(27,28). Previous data in aorta
from SHR showed the major contribution of NO in the
improvement of endothelial function provided by POM-
enriched diets consumption by increasing the aortic protein
expression of eNOS(7). In SMA, our findings showed that
relaxation to ACh was inhibited by L-NAME indicating the
participation of NO to the endothelial-dependent dilatation.
However, simultaneous blockade of COX and NOS by
indomethacin þ L-NAME only evoked a partial inhibition of
the relaxation to ACh, suggesting the substantial involvement
of EDHF. These findings agree with those demonstrated by
Fig. 6. Concentration–response curves for acetylcholine (ACh; 0·01–100mmol/l) in endothelium-intact isolated small mesenteric arteries (SMA) precontracted
with phenylephrine from spontaneously hypertensive rats fed a control basal diet (BD) (A), refined olive oil (OL) (B), pomace olive oil (POM) (C) or POM sup-
plemented in oleanolic acid (POMO) (D) for 12 weeks. Curves were obtained in SMA in the absence (W, taken as control) or presence of KCl 25 mmol/l (K), or
KCl 25 mmol/l þ indomethacin (10mmol/l) þ L-NAME (300mmol/l; O). Values are means with their standard errors, n 6. Mean value was significantly different from
the control in the absence of inhibitors (*P,0·05, **P,0·01, ***P,0·001). Mean value was significantly different from that in the presence of KCl 25 mmol/l þ
indomethacin þ L-NAME (†P,0·05, †††P,0·001).
Fig. 7. Bars showing contribution of NO/cyclo-oxygense (COX; A) and endothelium-derived hyperpolarising factor (EDHF; B) to the endothelial-dependent
response curve to acetylcholine (0·01–100mmol/l) in endothelium-intact isolated small mesenteric arteries precontracted with phenylephrine from Wistar–Kyoto
(A) or spontaneously hypertensive rats (B) fed a control basal diet (BD), refined olive oil (OL), pomace olive oil (POM) or POM supplemented in oleanolic acid
(POMO) for 12 weeks. Contributions were calculated from area under curves (AUC): NO/COX ¼ AUCKClþindo þ L-NAME 2 AUCKCl and EDHF ¼ AUCKClþindo þ L-
NAME 2 AUCindoþL-NAME. Mean value was significantly different from the NO/COX contribution (*P,0·05, **P,0·01, ***P,0·001). Mean value was significantly
different from that in the BD group (†P,0·05, ††P,0·01).
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Goto et al. (29) reporting that ACh evoked a fast depolarisation
in SMA from SHR, which was responsible for a constriction
that reduced EDHF-mediated relaxation. EDHF is abolished
by Kþ concentrations .25 mmol/l and is resistant to the
inhibitory action of indomethacin þ L-NAME(30), supporting
our observations. In SMA from SHR treated with POM, the
maximal relaxant response to ACh was substantially improved
compared with the rest of the dietary groups. Data generated
in the presence of Kþ 25 mmol/l confirmed the important
contribution of EDHF to the enhanced endothelium-dependent
relaxation in resistance arteries from SHR fed a POM diet. In
addition, and in contrast to the control group, the muscarinic
agonist also evoked dilatation in the second phase of the
dose–response curve in POM group. This phenomenon was
also observed in arteries from SHR fed a POMO diet.
Altogether, these observations support the notion that the
modulator effects of POM-enriched diets in the endothelial
dysfunction of resistance arteries from hypertensive rats
are related to an increased participation of the EDHF-type
component. Regarding to WKY rats fed a POM diet, the
relative contribution of NO/COX was more important com-
pared with SHR. This fact is in line with evidences that
EDHF- and NO-mediated dilatation in SMA from hyper-
tensive rats and mice showed a decreased NO and/or EDHF
contributions to relaxation(23,31).
In WKY rats treated with POMO diet, relaxation response
to ACh was enhanced by indomethacin, but there was a
contraction that remained unaltered at high concentrations
of ACh. This contraction was still remaining after
indomethacin þ L-NAME, but blocked by the additional pre-
sence of Kþ 25 mmol/l, suggesting that the contraction was
related to contracting agents different from the COX pathway.
Regarding to SHR fed a POMO diet, the participation of
NO was notably increased compared with the control group,
reaching similar levels of NO/EDHF contribution. The import-
ance of NO exhibited in POMO groups compared with
POM may be due to the higher concentration of oleanolic
acid in the former. As previously described, this triterpenoid
induces in vitro vasodilatation in conductance and resistance
arteries with endothelial NO as the main mediator of the
response(8 – 10). In addition, an increased NO bioavailability
was described as the major mechanism underlying the endo-
thelial function improvement in aorta from rats fed a POMO
diet. In this case, oleanolic acid was also suggested as a key
component responsible for this effect(7).
In the present study, blood pressure values were not altered
by any of the experimental diets, suggesting that changes in
endothelial function associated to POM intake could not be
explained by a secondary event to antihypertensive action,
but by a protective activity in the vascular endothelium
of resistance arteries. Diets were administered to SHR for
3 months, which may not have been long enough to observe
the effects of POM in blood pressure; however, beneficial
effects of these diets on endothelial function have been
detected after this treatment period. Therefore, it remains to
be determined whether a longer duration of treatment with
POM/POMO would affect blood pressure.
Functional and structural changes of resistance arteries may
represent the earliest type of hypertensive organ damage, and,
as such, is a potential treatment target(32). A number of very
recent investigations evidence that either POM intake or
some of its isolated triterpenoids substantially modify
the endothelial dysfunction associated to hypertension
and atherogenesis(7 – 10,33,34). Our present study shows that
these beneficial effects are further related to an improved
endothelial function in small mesenteric resistance arteries
from SHR after long-term intake of POM-enriched diets.
The mechanisms underlying this effect involve enhancement
of agonist-mediated EDHF/NO response, which is importantly
altered in the dysfunctional endothelium with hypertension.
The results also suggest that the triterpenic fraction may confer
a protective role to POM against endothelial dysfunction in
pathological situations such as hypertension and atherosclerosis.
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